Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
D
Dabas, Yakshi
The Rockefeller University
Paper 08 - DEFICIENCY OF ATRX RESHAPES CHROMATIN LANDSCAPES AND LEADS TO ABERRANT LINEAGE COMMITMENT IN MESENCHYMAL PROGENITORS AND ALTERED INFLAMMATORY PATHWAYS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Yakshi Dabas
Favorite
Dai, Dong
Daiichi Sankyo, Inc.
Paper 87 - PATIENT-REPORTED SYMPTOM IMPROVEMENT IN PATIENTS TREATED WITH PEXIDARTINIB FOR TENOSYNOVIAL GIANT CELL TUMOR: A CROSS-SECTIONAL SURVEY IN THE UNITED STATES
Dong Dai
Favorite
Daley, Jessica
University of Pittsburgh, UPMC Children's Hospital of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Jessica Daley
Favorite
Daly, Roger
Monash University
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Roger Daly
Favorite
D'Amato, Gina
University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Gina D'Amato
Favorite
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Gina D'Amato
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Gina D'Amato
Favorite
Dang, Alexa
BC Cancer
Paper 38 - PATIENT OUTCOMES IN METASTATIC EWING SARCOMA RESTRICTED TO PULMONARY METASTASES TREATED WITH WHOLE LUNG RADIATION
Alexa Dang
Favorite
D'Angelo, Sandra
Memorial Sloan Kettering Cancer Center
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Sandra D'Angelo
Favorite
Daskalopoulou, Christina
IQVIA
Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL
Christina Daskalopoulou
Favorite
Davies, Emma
Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Emma Davies
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Emma Davies
Favorite
Davis, Elizabeth
Vanderbilt University Medical Center
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Elizabeth Davis
Favorite
Davis, Korbin
Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Korbin Davis
Favorite
Davis, Lara
Oregon Health & Science University
Adolescent & Young Adult: Poster Highlights
Lara Davis
Favorite
Session 8: Adolescent & Young Adult Sarcoma
Location: VCC, East Exhibition Hall A
Lara Davis
Favorite
Daw, Najat
The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Najat Daw
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Najat Daw
Favorite
De Cecco, Loris
Fondazione IRCCS Istituto Nazionale Tumori
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Loris De Cecco
Favorite
De Cock, Lore
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Lore De Cock
Favorite
de Donno, G.
Image Science Institute, UMC Utrecht
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
G. de Donno
Favorite
De La Cuesta, Esther
Bayer HealthCare Pharmaceuticals, Inc.
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Esther De La Cuesta
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Esther De La Cuesta
Favorite
de Luca, Alberto
Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands; Neurology Department, UMC Utrecht Brain Center, University Medical Center Utrecht
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
Alberto de Luca
Favorite
de Miranda, Noel
Department of Pathology / Leiden Centre for Computational Oncology, Leiden University Medical Center
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Noel de Miranda
Favorite
De Sutter, Luna
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Luna De Sutter
Favorite
Debiec-Rychter, Maria
KU Leuven
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Maria Debiec-Rychter
Favorite
Dei Tos, Angelo
Azienda Ospedaliera di Padova
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Angelo Dei Tos
Favorite
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Angelo Dei Tos
Favorite
Dela Cruz, Filemon
Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Filemon Dela Cruz
Favorite
Delattre, Olivier
Institut Curie Research Center
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Olivier Delattre
Favorite
Delegido-Garcia, Ana
“La Arrixaca” Clinical University Hospital
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Ana Delegido-Garcia
Favorite
Demetri, George
Dana-Farber Cancer Institute and Ludwig Center at Harvard Medical School
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
George Demetri
Favorite
Demicco, Elizabeth
Mount Sinai Hospital, University of Toronto
Debate on Genomics: Should Patients with Sarcoma Have Next Generation Sequencing Performed at the Time of Diagnosis?
Location: VCC, East Exhibition Hall A
Elizabeth Demicco
Favorite
Deng, Jie
University of California, Los Angeles
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Jie Deng
Favorite
Deroose, Jan
Martini ziekenhuis
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Jan Deroose
Favorite
Desai, Anant
University Hospital Birmingham NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Anant Desai
Favorite
Desai, Jayesh
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Jayesh Desai
Favorite
Desar, Ingrid
Radboud University Medical Centre
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Ingrid Desar
Favorite
Deshpande, Hari
Yale
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Hari Deshpande
Favorite
Devalck, C
Paediatric Haematology and Oncology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
C Devalck
Favorite
Dewji, Simin
Mount Sinai Hospital
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Simin Dewji
Favorite
Dhami, Pawan
University College London Cancer Institute
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Pawan Dhami
Favorite
Dhir, Aditi
University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Aditi Dhir
Favorite
Di Lorenzo, Giorgia
Fondazione IRCCS Istituto Nazionale dei Tumori-Università degli studi Milano-Bicocca
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Giorgia Di Lorenzo
Favorite
di Paolo, P.L.
Department of Radiology, Bambino Gesù Children's Hospital, IRCCS
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
P.L. di Paolo
Favorite
Dickson, Brendan
Mount Sinai Hospital
Paper 32 - ESTABLISHMENT OF HIGH-GRADE SOFT TISSUE SARCOMA METASTATIC DISEASE MURINE MODELS
Brendan Dickson
Favorite
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Brendan Dickson
Favorite
Dickson, Brendan C
Department of Laboratory Medicine and Pathobiology, University of Toronto; Department of Pathology and Laboratory Medicine
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Brendan C Dickson
Favorite
Dickson, Mark
Memorial Sloan Kettering Cancer Center
Debate on Genomics: Should Patients with Sarcoma Have Next Generation Sequencing Performed at the Time of Diagnosis?
Location: VCC, East Exhibition Hall A
Mark Dickson
Favorite
Mentorship Session 1: How to Set Up Clinical Trials
Mark Dickson
Favorite
Session 3: Medical & Pediatric Oncology and Clinical Trials
Location: VCC, East Exhibition Hall A
Mark Dickson
Favorite
Session 6: Radiation Oncology & Oligometastatic Disease
Location: VCC, East Exhibition Hall A
Mark Dickson
Favorite
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Mark Dickson
Favorite
Dijkstra, Sander D.S.
Department of Surgery, Leiden University Medical Center
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Sander D.S. Dijkstra
Favorite
Dileo, Palma
University College London Hospitals NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Palma Dileo
Favorite
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Palma Dileo
Favorite
Dima, Laura
Bayer HealthCare SAS, Medical Affairs
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Laura Dima
Favorite
Dirksen, Uta
University Hospital Essen, Pediatrics III, Essen, Germany
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Uta Dirksen
Favorite
Djafarrian, Reza
Centre Hospitalier Universitaire Vaudois
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Reza Djafarrian
Favorite
Dorsey*, Jen
Lunenfeld Tanenbaum Research Institute/Mount Sinai Hospital
Paper 32 - ESTABLISHMENT OF HIGH-GRADE SOFT TISSUE SARCOMA METASTATIC DISEASE MURINE MODELS
Jen Dorsey*
Favorite
Doung, Yee
Oregon Health & Science University
Paper 84 - NATURAL LANGUAGE PROCESSING OF PATHOLOGY REPORTS IDENTIFIES SOFT TISSUE SARCOMAS MISSED BY INTERNATIONAL CLASSIFICATION OF DISEASES CODES IN THE VA NATIONAL DATABASE
Yee Doung
Favorite
Drechsler, Christine
The healthcare business of Merck KGaA
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Christine Drechsler
Favorite
Drusbosky, Leylah
Guardant Health
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Leylah Drusbosky
Favorite
D'Silva, Dhiren
PTC Therapeutics, Inc.
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Dhiren D'Silva
Favorite
Duarte, Carlos
Instituto Nacional de Cancerología
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Carlos Duarte
Favorite
DuBois, Steven
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Steven DuBois
Favorite
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Steven DuBois
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Steven DuBois
Favorite
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Steven DuBois
Favorite
Dufresne, Armelle
Medical Cancer Department, Centre Léon Bérard
Session 7: GIST & Other Sarcomas with Actionable Targets
Location: VCC, East Exhibition Hall A
Armelle Dufresne
Favorite
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Armelle Dufresne
Favorite
Durland-Busbice, Sara
Boehringer Ingelheim Pharmaceuticals Inc
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Sara Durland-Busbice
Favorite
Back to Top
